Atlas Trials

Safety, Tolerability, and Pharmacokinetic Study of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis

Clinical trial NCT03727802 · COMPLETED

Trial details

NCT number
NCT03727802
Sponsor
Toray Industries, Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Idiopathic Pulmonary Fibrosis
Start date
2018-11-28
Primary completion
2022-04-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.